Autoimmune disorders are a condition in which the body’s immune system mistakenly attacks and destroys the body’s healthy tissues by perceiving them as foreign bodies. The majority of autoimmune disorders cause inflammation of affected parts of the body. The most commonly occurring autoimmune disorders include psoriasis, systemic lupus erythematosus, and rheumatoid arthritis.
The increase in the aging population will be one of the significant trends in the global autoimmune disorder drug delivery devices market during 2019-2030. Globally, there is an increase in the aging population due to declining fertility and increasing longevity. This has increased the risk of developing autoimmune disorders such as psoriasis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, and rheumatoid arthritis.
According to the recent market intelligence published by BIS Research, the global autoimmune disorder drug delivery devices market was valued to be $1,685.2 million in 2019 and is expected to reach $10,686.5 million by 2030. The market is expected to grow at a CAGR of 15.25% during 2020-2030.
Rheumatoid Arthritis: It is one of the most common types of autoimmune disorders, and it is caused by the malfunctioning of the body’s immune system. The rheumatoid arthritis therapeutics market can dominate the global autoimmune disorder drug delivery devices market in the coming years. The market for rheumatoid arthritis is majorly driven by the high adoption of self-injection solutions, rise in the geriatric population, and increased life expectancy. Some major companies providing rheumatoid arthritis drug delivery devices include AbbVie Inc., Amgen Inc., F. Hoffmann- La Roche Ltd., and Bristol Myers Squibb Company.
Psoriasis: Psoriasis is an immune-mediated disease that causes inflammation in the body. There are usually physical signs of inflammation, such as red, itchy, scaly patches on the skin. The disorder causes the skin cells to grow and shed in three to four days, usually in a month. This is a lifelong chronic condition that has no cure. Only the symptoms can be managed with proper treatment and care. The psoriasis drug delivery devices can become the second-largest contributor to the autoimmune disorder drug delivery devices market during the forecast period. The need for psoriasis is majorly driven by the high adoption of self-injection solutions, extensive clinical trials, and increased demand for novel therapeutics in the market.
Multiple Sclerosis (MS): It is a neurological disorder that can gradually affect the brain, spinal cord and causes symptoms, including problems with vision, arm or leg movement, sensation, or balance. MS is a lifelong condition that can sometimes cause severe disability, although it can occasionally be mild. In many cases of MS, it is possible to treat the symptoms at an early stage. The increasing patient population, greater screening, and need for better treatment options are expected to be the major driving factors for the multiple sclerosis drug delivery devices market. The high cost of drugs to treat MS and the significant gap between early diagnosis and the actual initiation of therapy remains a critical restraining factor of this market during the forecast period.
Inflammatory Bowel Diseases (IBD): This includes autoimmune disorders that involve chronic inflammation of the digestive tract. These involve severe diarrhea, abdominal pain, fatigue, and weight loss. Types of IBD include ulcerative colitis – this disease includes chronic inflammation and sores in the large intestine (colon) and rectum, Crohn’s disease – this disease includes chronic inflammation and sores in the digestive tract lining. The IBD drug delivery devices market is expected to grow at the second-fastest rate during the forecast period. Humira and Simponi are the leading products when it comes to therapeutics corresponding to the devices. The market is majorly driven by the high adoption of self-injection solutions, a rise in the geriatric population, and increased demand for novel therapeutics in the IBD market. The pen injectors are currently dominating the IBD market by delivery devices.
Systemic lupus erythematosus (SLE): It is the most common form of lupus. It is a form of autoimmune disease in which the body attacks its tissues, causing widespread inflammation and tissue damage. It can affect the joints, skin, brain, lungs, kidneys, and blood vessels. No cure is available for SLE, but it can be managed with the help of drugs. SLE can be a potentially life-threatening disease if not taken care of properly. The primary causes include hormonal, environmental, or genetic changes. The market for SLE is majorly driven by increasing research and development in the field of SLE, advancements in the field of self-injection devices, and better treatment options available.